OMERSMALL

Omeros Corporation

HealthcareBiotechnology
$14.83
$0.00(+0.41%)
52W$2.95
$17.65
Updated May 6, 12:00 AM
RSI70
RS Rating94/99
Beta0.79
Volatility117%
F-Score3/9
Mkt Cap$1.0B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Omeros Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings growth of 16% provides fundamental context to the price action. However, price is extended 23% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
94
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.79
vs S&P 500
DEFENSIVE
52W Position
81%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$12.09
50 SMA > 100 SMA$12.12
100 SMA > 150 SMA$10.64
150 SMA > 200 SMA$9.01

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$13.51+9.79%ABOVE
50 SMA$12.09+22.65%ABOVE
100 SMA$12.12+22.40%ABOVE
150 SMA$10.64+39.35%ABOVE
200 SMA$9.01+64.52%ABOVE

Price Performance

1D+0.4%
1W+1.9%
1M+36.2%
3M+32.1%
6M+125.4%
YTD-9.5%
1Y+133.9%
3Y+43.7%
52-Week Trading Range81% from low
$14.83
52W Low$2.95
52W High$17.65

Technical Indicators

RSI (14)OVERBOUGHT
70.0
305070
VCP ScoreCOOL
3/10
Base depth: 37.4%

Risk Profile

Beta
0.79
52W Vol
117%
ATR
$0.69
Max DD (1Y)
-59%

Volume Analysis

Today
521.1K
50D Avg
1.04M
Vol Ratio
0.50x
Liquidity
MODERATE

Earnings Momentum

Q4'24-260%
$-0.54
Q1'25+8%
$-0.58
Q2'25+56%
$-0.43
Q3'25+16%
$-0.47
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+12.55%

Stock Price CAGR

10 Years:+1.82%
5 Years:-3.32%
3 Years:+43.68%
1 Year:+133.91%

Return on Equity

10Y Avg:-168.1%
5Y Avg:-256.7%
3Y Avg:-150.8%
Last Year:

Key Metrics

Market Cap$1.0B
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is OMER in an uptrend right now?

OMER has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is OMER overbought or oversold?

OMER's RSI (14) is 70. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is OMER outperforming the market?

OMER has a Relative Strength (RS) Rating of 94 out of 99. Yes, OMER is a market leader, outperforming 94% of all stocks over the past 12 months.

Where is OMER in its 52-week range?

OMER is trading at $14.83, which is 84% of its 52-week high ($17.65) and 81% above its 52-week low ($2.95).

How volatile is OMER?

OMER has a Beta of 0.79 and 52-week volatility of 117%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.